Stereotactic radioablation for ventricular tachycardia; [Stereotaktische Radioablation von ventrikulären Tachykardien]

被引：5

作者：

Hohmann S. ^{[1
]}

Hillmann H.A.K. ^{[1
]}

Müller-Leisse J. ^{[1
]}

Eiringhaus J. ^{[1
]}

Zormpas C. ^{[1
]}

Merten R. ^{[2
]}

Veltmann C. ^{[1
]}

Duncker D. ^{[1
]}

机构：

[1] Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover

[2] Department of Radiotherapy, Hannover Medical School, Hannover

来源：

Herzschrittmachertherapie + Elektrophysiologie | 2022年 / 33卷 / 1期

关键词：

Cardiac radioablation; Catheter ablation; Multimodal imaging; Stereotactic ablative body radiation; VT;

D O I：

10.1007/s00399-021-00830-y

中图分类号：

学科分类号：

摘要：

Non-invasive stereotactic radioablation of ventricular tachycardia (VT) substrate has been proposed as a novel treatment modality for patients not eligible for catheter-based ablation or in whom this approach has failed. Initial clinical results are promising with good short-term efficacy in VT suppression and tolerable side effects. This article reviews the current clinical evidence for cardiac radioablation and gives an overview of important preclinical and translational results. Practical guidance is provided, and a cardiac radioablation planning and treatment workflow based on expert consensus and the authorsʼ institutional experience is set out. © 2021, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

引用

页码：49 / 54

页数：5

共 41 条

[1] Aguilar M., Qian P.C., Boeck M., Et al., The rapidly-developing area of radiocardiology: principles, complications and applications of radiotherapy on the heart, Can J Cardiol, (2021)
[2] Bergom C., Bradley J.A., Ng A.K., Et al., Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification, JACC CardioOncol, 3, pp. 343-359, (2021)
[3] Bhaskaran A., Downar E., Chauhan V.S., Et al., Electroanatomical mapping-guided stereotactic radiotherapy for right ventricular tachycardia storm, Heart Rhythm Case Rep, 5, pp. 590-592, (2019)
[4] Bhaskaran A., Nayyar S., Porta-Sanchez A., Et al., Exit sites on the epicardium rarely subtend critical diastolic path of ischemic VT on the endocardium: implications for noninvasive ablation, J Cardiovasc Electrophysiol, 30, pp. 520-527, (2019)
[5] Blanck O., Buergy D., Vens M., Et al., Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA), Clin Res Cardiol, 109, pp. 1319-1332, (2020)
[6] Blatt J.A., Poole J.E., Johnson G.W., Et al., No benefit from defibrillation threshold testing in the SCD-HeFT (sudden cardiac death in heart failure trial), J Am Coll Cardiol, 52, pp. 551-556, (2008)
[7] Bode F., Blanck O., Gebhard M., Et al., Pulmonary vein isolation by radiosurgery: implications for non-invasive treatment of atrial fibrillation, Europace, 17, pp. 1868-1874, (2015)
[8] Brett C.L., Cook J.A., Aboud A.A., Et al., Novel workflow for conversion of catheter-based electroanatomic mapping to DICOM imaging for noninvasive radioablation of ventricular tachycardia, Pract Radiat Oncol, 11, pp. 84-88, (2020)
[9] Cha M., Seo J., Kim H.J., Et al., Early changes in rat heart after high-dose irradiation: implications for antiarrhythmic effects of cardiac radioablation, J Am Heart Assoc, 10, (2021)
[10] Chin R., Hayase J., Hu P., Et al., Non-invasive stereotactic body radiation therapy for refractory ventricular arrhythmias: an institutional experience, J Interv Card Electrophysiol, 61, pp. 535-543, (2021)

← 1 2 3 4 5 →